Heart (British Cardiac Society) · 2026
Comparison between three single-dose cardioplegic solutions in myocardial protection: Cardioplegia Trial - a double-blind randomised clinical trial.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lira Kathize Betti, Delvaux Renan Senandes, Spadini Felipe Abatti, Anschau Fernando, Kopittke Luciane, Rode Juarez, Ceron Rafael Oliveira, Rey Rafael Antônio Widholzer, Wittke Estefania Inez, Rombaldi Alfeu Roberto, Oliveira Alexsandro Rodrigues, Rodrigues Cristine Lunardi, Pereira Carla Helena, Almeida Adriana Silveira
Аннотация
OBJECTIVES: To compare myocardial protection afforded by three single-dose cardioplegic solutions - Custodiol (HTK), del Nido (DN) and modified del Nido (MDN) - in adult elective cardiac surgery.
DESIGN: Double-blind randomised controlled trial.
SETTING: Tertiary hospital in southern Brazil.
PARTICIPANTS: 99 adults undergoing elective valve or coronary artery bypass surgery with cardiopulmonary bypass.
INTERVENTIONS: Administration of HTK, DN or MDN solution during surgery.
MAIN OUTCOME MEASURES: High-sensitivity cardiac troponin T (hs-cTnT) at 0, 2, 12 and 24 hours postoperatively. Additionally, indirect measures of myocardial protection were compared, both laboratory and clinical, during intraoperative and postoperative periods.
RESULTS: All solutions provided effective myocardial protection, with similar clinical and laboratory outcomes. DN was associated with significantly lower hs-cTnT at 2 hours (p=0.023) and fewer intraoperative transfusions (p=0.008). HTK patients had lower postoperative sodium and potassium levels (p=0.049 and p=0.002, respectively). Survival and major postoperative outcomes, including vasoactive or mechanical support, were similar across groups.
CONCLUSIONS: The three cardioplegic strategies showed comparable biochemical profiles of myocardial injury. DN was associated with lower early troponin release and reduced transfusion requirements, while HTK produced transient electrolyte shifts.
TRIAL REGISTRATION NUMBER: ReBEC; RBR-7g5s66.
DESIGN: Double-blind randomised controlled trial.
SETTING: Tertiary hospital in southern Brazil.
PARTICIPANTS: 99 adults undergoing elective valve or coronary artery bypass surgery with cardiopulmonary bypass.
INTERVENTIONS: Administration of HTK, DN or MDN solution during surgery.
MAIN OUTCOME MEASURES: High-sensitivity cardiac troponin T (hs-cTnT) at 0, 2, 12 and 24 hours postoperatively. Additionally, indirect measures of myocardial protection were compared, both laboratory and clinical, during intraoperative and postoperative periods.
RESULTS: All solutions provided effective myocardial protection, with similar clinical and laboratory outcomes. DN was associated with significantly lower hs-cTnT at 2 hours (p=0.023) and fewer intraoperative transfusions (p=0.008). HTK patients had lower postoperative sodium and potassium levels (p=0.049 and p=0.002, respectively). Survival and major postoperative outcomes, including vasoactive or mechanical support, were similar across groups.
CONCLUSIONS: The three cardioplegic strategies showed comparable biochemical profiles of myocardial injury. DN was associated with lower early troponin release and reduced transfusion requirements, while HTK produced transient electrolyte shifts.
TRIAL REGISTRATION NUMBER: ReBEC; RBR-7g5s66.